Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENCHANTED: Low-dose rtPA and Intensive BP Lowering in Acute Ischaemic Stroke
NCT01422616Phase 3Completed
- Sponsor
- The George Institute for Global Health
- Start
- Mar 2012
- Primary completion
- Aug 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in ischemic stroke, sponsored by The George Institute for Global Health. Started Mar 2012; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01422616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01422616.